Skip to main content

Henry Hagopian III

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Henry Hagopian III

Henry Hagopian III is recorded as CFO at Annovis Bio, Inc. (ANVS). Annovis Bio, Inc. reported in an 8-K filed May 1, 2024 that Henry Hagopian III resigned as Chief Financial Officer and principal financial officer, effective April 30, 2024. Annovis Bio, Inc. reported in an 8-K filed August 30, 2022 that Henry Hagopian III was appointed Chief Financial Officer, effective August 29, 2022. The proxy statement of Annovis Bio, Inc. reports total compensation of $490,873 for Henry Hagopian III in fiscal 2023, including a base salary of $375,000. Disclosed compensation is on record for 3 fiscal years.

“Effective as of the close of business on April 30, 2024, Henry Hagopian is no longer serving as the Chief Financial Officer and as principal financial officer of Annovis Bio, Inc. (the "Company").”
Annovis Bio, Inc. Form 8-K, filed May 1, 2024 · Read the filing
“On August 29, 2022, the Board of Directors of Annovis Bio, Inc. (the "Company") appointed Henry Hagopian III, age 54, as Chief Financial Officer of the Company, effective immediately, to replace Jeffrey McGroarty.”
Annovis Bio, Inc. Form 8-K, filed August 30, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Annovis Bio, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Annovis Bio, Inc. (ANVS) $375,000 $490,873
2022 Annovis Bio, Inc. (ANVS) $129,327 $1,417,257
2021 Annovis Bio, Inc. (ANVS) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.